Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety & Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail

NCT01400594 is registered in ClinicalTrials.gov with Hisamitsu Pharmaceutical Co., Inc. as lead sponsor.

NCT NCT01400594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01400594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Parallel-Group, Multicenter, Placebo-Controlled Study of the Safety & Efficacy of HTU-520 in the Treatment of Mild to Moderate Distal Subungual Onychomycosis of the Toenail
Lead sponsor
Hisamitsu Pharmaceutical Co., Inc.
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2011
Completion date
January 31, 2013
Enrollment
182 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

onychomycosis